Biocryst Pharmaceuticals Inc BCRX
992 filings, 2 in the last 30 days
SEC filing indexWhat the 8-Ks said
2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Aug 4, 2026 RestructuringReported exit or disposal costs from a restructuring (amended) 8-K/A item 2.05 · all documents
- Jun 29, 2026 RestructuringReported exit or disposal costs from a restructuring “. Costs Associated with Exit or Disposal Activities. On June 25, 2026, the Board of Directors of BioCryst Pharmaceuticals, Inc. (the “Company”) approved a plan to discontinue the Company’s internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama (the “Plan”). The Plan was approved as part of the Company’s ongoing strategic evolution to strengthen…” 8-K item 2.05 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 61 events
- Nov 4, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 4, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Aug 5, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Aug 5, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Aug 4, 2026 8-K Restructuring or exit costs (amended)8-K item 2.05
- Jun 29, 2026 8-K Restructuring or exit costs, Regulation FD disclosure8-K items 2.05, 7.01
- Jun 12, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 18, 2026 Planned sale Amy McKee (Director) gave notice of a planned sale of 11,180 shares worth about $100KForm 144, approximate sale date May 18, 2026
- May 13, 2026 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 62,500 shares worth about $596KForm 144, approximate sale date May 13, 2026, under a 10b5-1 plan adopted Aug 13, 2025
- May 6, 2026 Planned sale Ron Dullinger (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 64,738 shares, runs to Feb 26, 2027
- May 6, 2026 Planned sale Jon Stonehouse (Member of the Board of Directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 800,000 shares, runs to Dec 31, 2027
- May 6, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 6, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- May 4, 2026 8-K Regulation FD disclosure8-K item 7.01
- Mar 20, 2026 Planned sale HEGGIE THERESA (Director) gave notice of a planned sale of 49,933 shares worth about $505KForm 144, approximate sale date Mar 20, 2026
- Mar 16, 2026 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 150,000 shares worth about $1.4MForm 144, approximate sale date Mar 16, 2026, under a 10b5-1 plan adopted Aug 13, 2025
- Mar 2, 2026 Planned sale Stonehouse Jon P (Director) gave notice of a planned sale of 305,995 shares worth about $2.6MForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted May 29, 2024
- Feb 26, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 26, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 23, 2026 8-K Director or officer change (amended)8-K item 5.02
- Jan 23, 2026 8-K Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Regulation FD disclosure8-K items 1.01, 2.01, 2.03, 7.01
- Jan 12, 2026 8-K Quarterly results, Regulation FD disclosure, Other events8-K items 2.02, 7.01, 8.01
- Jan 9, 2026 8-K Regulation FD disclosure8-K item 7.01
- Dec 22, 2025 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 21,773 shares worth about $167KForm 144, approximate sale date Dec 22, 2025, under a 10b5-1 plan adopted Aug 13, 2025
- Dec 15, 2025 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 21,210 shares worth about $162KForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted Aug 13, 2025
- Dec 12, 2025 8-K Other events8-K item 8.01
- Dec 11, 2025 8-K Director or officer change8-K item 5.02
- Dec 3, 2025 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 19,770 shares worth about $151KForm 144, approximate sale date Dec 3, 2025, under a 10b5-1 plan adopted Aug 13, 2025
- Dec 3, 2025 8-K Other events8-K item 8.01
- Dec 2, 2025 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 50,906 shares worth about $367KForm 144, approximate sale date Dec 2, 2025
- Dec 1, 2025 Planned sale Barnes Alane P (Officer) gave notice of a planned sale of 91,004 shares worth about $644KForm 144, approximate sale date Dec 1, 2025, under a 10b5-1 plan adopted Aug 13, 2025
- Nov 25, 2025 Planned sale Helen M Thackray (Officer) gave notice of a planned sale of 48,229 shares worth about $328KForm 144, approximate sale date Nov 25, 2025
- Nov 21, 2025 Planned sale Helen Thackray (Officer) gave notice of a planned sale of 43,275 shares worth about $308KForm 144, approximate sale date Nov 21, 2025
- Nov 13, 2025 Planned sale SANDERS MACHELLE (Officer) gave notice of a planned sale of 9,600 shares worth about $69KForm 144, approximate sale date Nov 13, 2025, under a 10b5-1 plan adopted Aug 14, 2025
- Nov 4, 2025 Planned sale A. Machelle Sanders (Member of the Board of Directors) adopted a 10b5-1 trading planreported in the 10-Q, up to 9,600 shares, runs to Dec 31, 2025
- Nov 4, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Nov 3, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Oct 14, 2025 8-K Material agreement signed, Quarterly results, Director or officer change, Other events8-K items 1.01, 2.02, 5.02, 8.01
- Oct 1, 2025 8-K Material agreement signed, Other events8-K items 1.01, 8.01
- Aug 11, 2025 8-K Director or officer change8-K item 5.02
- Aug 5, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Aug 4, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jul 31, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Jul 7, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Jun 30, 2025 8-K Material agreement signed8-K item 1.01
- Jun 27, 2025 8-K Other events8-K item 8.01
- Jun 25, 2025 8-K Other events8-K item 8.01
- Jun 16, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- Jun 4, 2025 8-K Director or officer change8-K item 5.02
- May 14, 2025 8-K Other events8-K item 8.01
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- May 5, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 1, 2025 8-K Director or officer change8-K item 5.02
- Apr 10, 2025 8-K Director or officer change8-K item 5.02
- Mar 11, 2025 8-K Other events8-K item 8.01
- Mar 4, 2025 8-K Director or officer change8-K item 5.02
- Feb 25, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 24, 2025 8-K Quarterly results, Regulation FD disclosure, Other events8-K items 2.02, 7.01, 8.01
- Jan 13, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jan 10, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jan 8, 2025 8-K Regulation FD disclosure8-K item 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 4, 2026 | 10-Q | Quarterly report |
| Nov 4, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Aug 14, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 5, 2026 | 10-Q | Quarterly report |
| Aug 5, 2026 | S-8 | Shares registered for employee plans |
| Aug 5, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Aug 4, 2026 | 8-K/A | Restructuring or exit costs |
| Jun 29, 2026 | 8-K | Restructuring or exit costs, Regulation FD disclosure |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 12, 2026 | 8-K | Director or officer change, Shareholder vote results |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| May 19, 2026 | 4 | Insider trade |
| May 18, 2026 | 144 | Notice of planned insider sale |
| May 15, 2026 | 4 | Insider trade |
| May 13, 2026 | 144 | Notice of planned insider sale |
| May 6, 2026 | 10-Q | Quarterly report |
| May 6, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| May 4, 2026 | 8-K | Regulation FD disclosure |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 23, 2026 | DEF 14A | Proxy statement |
| Apr 23, 2026 | ARS | Annual report to shareholders |
| Apr 23, 2026 | DEFA14A | Extra proxy material |
| Apr 7, 2026 | 3 | New insider |
| Apr 7, 2026 | 4 | Insider trade |
| Mar 26, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 24, 2026 | 4 | Insider trade |
| Mar 20, 2026 | 144 | Notice of planned insider sale |
| Mar 18, 2026 | 4 | Insider trade |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Feb 26, 2026 | 10-K | Annual report |
| Feb 26, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Feb 12, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jan 27, 2026 | 3 | New insider |
| Jan 27, 2026 | 4 | Insider trade |
| Jan 23, 2026 | 8-K/A | Director or officer change |
| Jan 23, 2026 | 8-K | Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Regulation FD disclosure |
| Jan 12, 2026 | 8-K | Quarterly results, Regulation FD disclosure, Other events |
| Jan 9, 2026 | 3 | New insider |
| Jan 9, 2026 | 8-K | Regulation FD disclosure |
| Dec 23, 2025 | 4 | Insider trade |
| Dec 23, 2025 | 4 | Insider trade |
| Dec 23, 2025 | 4 | Insider trade |
| Dec 22, 2025 | 144 | Notice of planned insider sale |
| Dec 19, 2025 | 4 | Insider trade |
| Dec 19, 2025 | 4 | Insider trade |
| Dec 19, 2025 | 4 | Insider trade |
| Dec 19, 2025 | 4 | Insider trade |
| Dec 18, 2025 | EFFECT | |
| Dec 18, 2025 | 424B3 | |
| Dec 16, 2025 | CORRESP | Company's reply to the SEC |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 15, 2025 | 144 | Notice of planned insider sale |
| Dec 15, 2025 | S-4/A | |
| Dec 12, 2025 | 8-K | Other events |
| Dec 11, 2025 | 8-K | Director or officer change |
| Dec 3, 2025 | 144 | Notice of planned insider sale |
| Dec 3, 2025 | 425 | |
| Dec 3, 2025 | 8-K | Other events |
| Dec 3, 2025 | 4 | Insider trade |
| Dec 2, 2025 | 144 | Notice of planned insider sale |
| Dec 2, 2025 | 4 | Insider trade |
| Dec 2, 2025 | 4 | Insider trade |
| Dec 2, 2025 | 4 | Insider trade |
| Dec 1, 2025 | 144 | Notice of planned insider sale |
| Nov 25, 2025 | 144 | Notice of planned insider sale |
| Nov 21, 2025 | 144 | Notice of planned insider sale |
| Nov 20, 2025 | S-4 | |
| Nov 17, 2025 | 4 | Insider trade |
| Nov 13, 2025 | 144 | Notice of planned insider sale |
| Nov 12, 2025 | SCHEDULE 13G | 5%+ owner (passive) |
| Nov 4, 2025 | 10-Q | Quarterly report |
| Nov 3, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| Oct 14, 2025 | 425 | |
| Oct 14, 2025 | 425 | |
| Oct 14, 2025 | 425 |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BCRX/export.csv") into a cell.